Study of an investigational weight-loss drug in women with overweight or obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests an investigational medication called eloralintide to see if it helps with weight loss in women who are overweight or have obesity. Participants will receive the study drug and be monitored for safety and effectiveness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman (assigned female at birth) and either cannot become pregnant or use non-hormonal birth control.
- Your body mass index (BMI) is between 27 and 35.
- Your weight has been stable (less than 5% change) for the past 3 months.
- You have no history of blood clots, liver disease, or certain cancers (like breast, uterine, or ovarian).
- You have not used hormonal birth control (like pills, patches, or implants) recently.
- You are not pregnant or breastfeeding and do not plan to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
This trial tests if adding eloralintide helps people who are still obese or overweight while taking weekly incretin therapy. It aims to support additional weight loss for those who haven't reached their goals.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.